Searle E, Campbell V, Pawlyn C, Vogl D, Holstein S, Gooding S, Jenner M, Creasey T, Chaidos A, Rodríguez-Otero P, Al-Kaisi F, Brearton A, Moore S, O’Nions J, Somervaille T, Knurowski T, Clegg K, Paul S, Frese K, Joseph N. P39 | RANDOMIZED PHASE II DOSE OPTIMIZATION STUDY OF INOBRODIB (CCS1477) IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14069